Travere Therapeutics (TVTX) PT Raised to $80 at Wells Fargo
Tweet
Share
E-mailGet Alerts TVTX Hot Sheet
Price: $63.07 -2.58%
Rating Summary:
12 Buy, 2 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Rating Summary:
12 Buy, 2 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Join SI Premium – FREE
Wells Fargo analyst Mohit Bansal raised the price target on Travere Therapeutics (NASDAQ: TVTX) to $80.00 (from $65.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Securitize Corp (SECZ) PT Raised to $12 at StoneX on 'Innovation Exemption'
- TIME dotCom Berhad (TDC:MK) PT Raised to MYR7.50 at JPMorgan
- HubSpot Inc (HUBS) PT Raised to $290 at UBS, Stock Expected to Be Execution-Driven Near-Term
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
